Towards Healthcare
Liquid Biopsy Tube Market Uplift USD 1.54 Billion in 2025

Liquid Biopsy Tube Market Forecast 2025 Innovation in DNA & RNA Tubes to Drive 14.85% CAGR Growth Till 2034

According to market projections, the liquid biopsy tube sector is expected to grow from USD 1.34 billion in 2024 to USD 5.32 billion by 2034, reflecting a CAGR of 14.85%. These specialized tubes offer a revolutionary alternative to traditional biopsy methods by improving patient comfort and enabling real-time disease monitoring.

Content

  • Insight Code: 5960
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The liquid biopsy tube market is projected to reach USD 5.32 billion by 2034, growing at a CAGR of 14.85% from 2024 to 2034.

North America is currently leading the Liquid Biopsy Tube market, due to a robust healthcare infrastructure and extensive funding in molecular diagnostics, prestigious clinical reference laboratories, and prominent oncology centers commonly utilize of DNA and RNA tubes for precise testing.

The market includes five segments such as Tube Type, additive preservation chemistry, application, end-user, and material.

Some key players include Streck, Inc., and Bio-Rad Laboratories, Inc.

Key trends include rising demand for minimally invasive diagnostics and advancements in precision oncology.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions